Del Sette Capital Management LLC Invests $2.15 Million in Intuitive Surgical, Inc. $ISRG

Del Sette Capital Management LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,804 shares of the medical equipment provider’s stock, valued at approximately $2,154,000. Intuitive Surgical comprises 1.3% of Del Sette Capital Management LLC’s holdings, making the stock its 28th largest position.

Other large investors also recently modified their holdings of the company. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Newbridge Financial Services Group Inc. boosted its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $27,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on ISRG shares. Argus reduced their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Truist Financial cut their target price on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. The Goldman Sachs Group raised their target price on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, April 22nd. Finally, Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research note on Wednesday, March 11th. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $457.78 on Friday. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88. The company has a market capitalization of $162.13 billion, a P/E ratio of 55.49, a price-to-earnings-growth ratio of 3.67 and a beta of 1.51. The company has a 50-day simple moving average of $474.86 and a 200 day simple moving average of $515.98.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.81 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.53 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 133 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 5,906 shares of company stock worth $2,907,726. 0.60% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.